Dead or alive: Immunogenicity of human melanoma cells when presented by dendritic cells

Cancer Research

Volumn 60, Issue 22, 2000, Pages 6441-6447

  Shaif Muthana, M ^a   McIntyre, C ^a   Sisley, K ^a   Rennie, I ^a   Murray, A ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; HLA ANTIGEN;

APOPTOSIS; ARTICLE; CANCER IMMUNOLOGY; CELL DEATH; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGENICITY; LYMPHOCYTE PROLIFERATION; MELANOMA CELL; PRIORITY JOURNAL; PROGNOSIS; UVEA MELANOMA;

ANTIGEN PRESENTATION; ANTIGENS, NEOPLASM; APOPTOSIS; CANCER VACCINES; COCULTURE TECHNIQUES; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; FLOW CYTOMETRY; HUMANS; LYMPHOCYTE ACTIVATION; MELANOMA; MICROSCOPY, ELECTRON; MICROSCOPY, FLUORESCENCE; NECROSIS; PHAGOCYTOSIS; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED; UVEAL NEOPLASMS; VACCINES, SYNTHETIC;

EID: 0033677265     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Immune responses against tumors
2. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma
3. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes
4. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas
5. Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes
6. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas
7. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor
8. Infrequent expression of the MAGE gene family in uveal melanomas
9. Recognition of melanoma-associated peptides by peripheral blood mononuclear cells of ocular melanoma patients
10. Immunologic and therapeutic evaluation of a synthetic peptide vaccination for the treatment of patients with metastatic melanoma
11. Tumor regression responses in melanoma patients treated with a peptide encoded by the gene MAGE-3
12. Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptides in vivo: Implications for tumor vaccines with melanoma-associated antigens
13. Dendritic cells as initiators of tumor immune responses: A possible strategy for tumor immunotherapy?
14. Dendritic cell vaccines for cancer immunotherapy
15. Identifying strategies for immune intervention
16. Generation of antimelanoma cytotoxic T lymphocytes from healthy donors after presentation of melanoma-associated antigen-derived epitopes by dendritic cells in vitro
17. Human dendritic cells, pulsed with either melanoma tumor cell lysates or the gp100 peptide (280-288), induce pairs of T-cell cultures with similar phenotype and lytic activity
18. Vaccination of melanoma patients with peptide- or lysate-pulsed dendritic cells
19. Tumor antigens recognized by T lymphocytes
20. Pivotal role of the B7:CD28 pathway in transplantation and tumor immunity
21. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
22. Processing of engulfed apoptotic cells yields T cell epitopes
23. Apoptosis in the pathogenesis and treatment of disease
24. Proliferating dendritic cell progenitors in human blood
25. Efficient presentation of soluble antigen by cultured dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin-4 and downregulated by tumor necrosis factor-α
26. The selective engulfment of apoptotic bodies by dendritic cells is mediated by the αvβ3 integrin and requires intracellular and extracellular calcium
27. Rejection of nonimmunogenic melanoma by vaccination with natural melanoma peptides on engineered antigen presenting cells
28. Immature dendritic cells phagocytose apoptotic cells via αvβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes
29. Anti-HLA-A2 antibody-enhancement of peptide association with HLA-A2 as detected by cytotoxic T lymphocytes
30. Uveal melanoma: The past, the present and the future
31. The radiosensitivity of uveal melanoma cells and the cell survival curve
32. Radiation sensitivity in vitro of primary tumors and metastatic lesions of malignant melanoma
33. Single-dose compared with fractionated-dose radiation of the OM431 choroidal melanoma cell line
34. Immunogenicity of apoptotic cell in vivo: Role of antigen load, antigen presenting cells and cytokines
35. Chromatin cleavage in apoptosis: Association with condensed chromatin morphology and dependence on macromolecular synthesis
36. Apoptosis
37. Phagocytic recognition of cells undergoing apoptosis
38. Apoptosis: The importance of being eaten
39. Induction of antitumor immunity by immunization with fusions of dendritic and carcinoma cells
40. Dendritic cells stimulate primary human cytolytic responses in the absence of CD4+ helper T cells
41. Induction of cytotoxic T-cell response in the absence of CD4 helper cells
42. Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells
43. + T-cells by B7-transfected melanoma cells
44. Costimulation of antitumor immunity by the B7 counter-receptor for the T lymphocyte molecules CD28 and CTLA-4
45. Induction of apoptosis reduces immunogenicity of human T-cell lines in mice
46. Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression
47. Differential effect of apoptotic versus necrotic tumor cells on macrophage antitumor activities
48. Natural adjuvants: Endogenous activators of dendritic cells
49. The immunological potential of apoptotic debris produced by tumor cells during HIV infection
50. Immunosuppressive effects of apoptotic cells
51. Haplotype-specific suppression of cytotoxic T cell induction by antigen inappropriately presented on T cells
52. Restoration of viral immunity in immuno-deficient humans by the adoptive transfer of T cell clones
53. Death, destruction, danger and dendritic cells
54. Bystander apoptosis triggers dendritic cell maturation and antigen-presenting function
55. + T-cell tolerance to T-cell priming through in vivo ligation of CD40